XML 33 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement of Previously Issued Financial Statements

 

 

June 30,

 

 

 

2024

 

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

809,146

 

 

$

 

 

$

 

 

$

809,146

 

Accounts receivable, net of reserves of $1,823 and $2,122 at
   June 30, 2024 and December 31, 2023, respectively

 

 

123,245

 

 

 

 

 

 

 

 

 

123,245

 

Inventories, net

 

 

190,528

 

 

 

 

 

 

 

 

 

190,528

 

Assets held for sale

 

 

1,016

 

 

 

 

 

 

 

 

 

1,016

 

Prepaid expenses and other current assets

 

 

34,983

 

 

 

(2,397

)

 

 

244

 

 

 

32,830

 

Total current assets

 

 

1,158,918

 

 

 

(2,397

)

 

 

244

 

 

 

1,156,765

 

Noncurrent assets:

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

204,599

 

 

 

 

 

 

 

 

 

204,599

 

Intangible assets, net

 

 

379,813

 

 

 

 

 

 

6,235

 

 

 

386,048

 

Goodwill

 

 

985,613

 

 

 

 

 

 

 

 

 

985,613

 

Deferred tax assets

 

 

678

 

 

 

 

 

 

 

 

 

678

 

Operating lease right of use assets

 

 

131,450

 

 

 

 

 

 

 

 

 

131,450

 

Other noncurrent assets

 

 

853

 

 

 

 

 

 

 

 

 

853

 

Total noncurrent assets

 

 

1,703,006

 

 

 

 

 

 

6,235

 

 

 

1,709,241

 

Total assets

 

$

2,861,924

 

 

$

(2,397

)

 

$

6,479

 

 

$

2,866,006

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

20,910

 

 

$

 

 

$

 

 

$

20,910

 

Operating lease liability

 

 

12,129

 

 

 

 

 

 

 

 

 

12,129

 

Current contingent consideration

 

 

13,936

 

 

 

 

 

 

 

 

 

13,936

 

Accrued liabilities

 

 

57,851

 

 

 

498

 

 

 

 

 

 

58,349

 

Convertible Senior Notes due 2024, net

 

 

69,481

 

 

 

 

 

 

 

 

 

69,481

 

Total current liabilities

 

 

174,307

 

 

 

498

 

 

 

 

 

 

174,805

 

Noncurrent liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Convertible Senior Notes due 2028, net

 

 

517,725

 

 

 

 

 

 

 

 

 

517,725

 

Deferred tax liabilities

 

 

36,305

 

 

 

(1,903

)

 

 

(358

)

 

 

34,044

 

Noncurrent operating lease liability

 

 

143,518

 

 

 

 

 

 

 

 

 

143,518

 

Noncurrent contingent consideration

 

 

 

 

 

 

 

 

 

 

 

 

Other noncurrent liabilities

 

 

3,707

 

 

 

 

 

 

7,769

 

 

 

11,476

 

Total noncurrent liabilities

 

 

701,255

 

 

 

(1,903

)

 

 

7,411

 

 

 

706,763

 

Total liabilities

 

 

875,562

 

 

 

(1,405

)

 

 

7,411

 

 

 

881,568

 

Commitments and contingencies (Note 11)

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares
   issued or outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 80,000,000 shares authorized; 55,902,860
   shares at June 30, 2024 and
55,766,078 shares at December 31, 2023
   issued and outstanding

 

 

559

 

 

 

 

 

 

 

 

 

559

 

Additional paid-in capital

 

 

1,585,782

 

 

 

 

 

 

665

 

 

 

1,586,447

 

Accumulated other comprehensive loss

 

 

(44,243

)

 

 

(202

)

 

 

 

 

 

(44,445

)

Accumulated earnings

 

 

444,264

 

 

 

(790

)

 

 

(1,597

)

 

 

441,877

 

Total stockholders’ equity

 

 

1,986,362

 

 

 

(992

)

 

 

(932

)

 

 

1,984,438

 

Total liabilities and stockholders’ equity

 

$

2,861,924

 

 

$

(2,397

)

 

$

6,479

 

 

$

2,866,006

 

 

 

 

 

Three Months Ended June 30, 2024

 

 

Six Months Ended June 30, 2024

 

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

$

154,038

 

 

$

4,766

 

 

$

 

 

$

158,804

 

 

$

305,348

 

 

$

6,602

 

 

$

 

 

$

311,950

 

Royalty and other revenue

 

 

35

 

 

 

 

 

 

 

 

 

35

 

 

 

71

 

 

 

 

 

 

 

 

 

71

 

Total revenue

 

 

154,073

 

 

 

4,766

 

 

 

 

 

 

158,839

 

 

 

305,419

 

 

 

6,602

 

 

 

 

 

 

312,021

 

Costs and operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

77,314

 

 

 

 

 

 

 

 

 

77,314

 

 

 

153,705

 

 

 

 

 

 

 

 

 

153,705

 

Research and development

 

 

10,575

 

 

 

 

 

 

 

 

 

10,575

 

 

 

21,813

 

 

 

 

 

 

 

 

 

21,813

 

Selling, general and administrative

 

 

64,697

 

 

 

 

 

 

784

 

 

 

65,481

 

 

 

126,383

 

 

 

 

 

 

901

 

 

 

127,284

 

Contingent consideration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total costs and operating expenses

 

 

152,586

 

 

 

 

 

 

784

 

 

 

153,370

 

 

 

301,901

 

 

 

 

 

 

901

 

 

 

302,802

 

Income from operations

 

 

1,487

 

 

 

4,766

 

 

 

(784

)

 

 

5,469

 

 

 

3,518

 

 

 

6,602

 

 

 

(901

)

 

 

9,219

 

Other income (expenses):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment income

 

 

9,411

 

 

 

 

 

 

 

 

 

9,411

 

 

 

18,404

 

 

 

 

 

 

 

 

 

18,404

 

Interest expense

 

 

(4,981

)

 

 

 

 

 

(137

)

 

 

(5,118

)

 

 

(9,872

)

 

 

 

 

 

(275

)

 

 

(10,147

)

Amortization of debt issuance costs

 

 

(520

)

 

 

 

 

 

 

 

 

(520

)

 

 

(1,003

)

 

 

 

 

 

 

 

 

(1,003

)

Other (expenses) income

 

 

(215

)

 

 

 

 

 

 

 

 

(215

)

 

 

(3,751

)

 

 

 

 

 

 

 

 

(3,751

)

Other income, net

 

 

3,695

 

 

 

 

 

 

(137

)

 

 

3,558

 

 

 

3,778

 

 

 

 

 

 

(275

)

 

 

3,503

 

Income before income taxes

 

 

5,182

 

 

 

4,766

 

 

 

(921

)

 

 

9,027

 

 

 

7,296

 

 

 

6,602

 

 

 

(1,176

)

 

 

12,722

 

Income tax provision

 

 

1,861

 

 

 

1,757

 

 

 

(304

)

 

 

3,314

 

 

 

1,881

 

 

 

2,195

 

 

 

(363

)

 

 

3,713

 

Net income

 

$

3,321

 

 

$

3,009

 

 

$

(617

)

 

$

5,713

 

 

$

5,415

 

 

$

4,407

 

 

$

(813

)

 

$

9,009

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.06

 

 

$

0.05

 

 

$

(0.01

)

 

$

0.10

 

 

$

0.10

 

 

$

0.08

 

 

$

(0.02

)

 

$

0.16

 

Diluted (Note 13)

 

$

0.06

 

 

$

0.05

 

 

$

(0.01

)

 

$

0.10

 

 

$

0.10

 

 

$

0.08

 

 

$

(0.02

)

 

$

0.16

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

55,884

 

 

 

 

 

 

 

 

 

55,884

 

 

 

55,838

 

 

 

 

 

 

 

 

 

55,838

 

Diluted (Note 13)

 

 

56,434

 

 

 

 

 

 

 

 

 

56,434

 

 

 

56,477

 

 

 

 

 

 

 

 

 

56,477

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

3,321

 

 

$

3,009

 

 

$

(617

)

 

$

5,713

 

 

$

5,415

 

 

$

4,407

 

 

$

(813

)

 

$

9,009

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

(1,531

)

 

 

28

 

 

 

 

 

 

(1,503

)

 

 

(6,812

)

 

 

175

 

 

 

 

 

 

(6,637

)

Comprehensive income (loss)

 

$

1,790

 

 

$

3,037

 

 

$

(617

)

 

$

4,210

 

 

$

(1,397

)

 

$

4,582

 

 

$

(813

)

 

$

2,372

 

 

 

 

 

Additional Paid-In Capital

 

 

Accumulated Other Comprehensive Loss

 

 

Accumulated Earnings

 

 

Total Stockholders' Equity

 

 

 

As Previously Reported

 

 

Other Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Balance at March 31, 2024

 

 

1,571,811

 

 

 

 

 

 

1,571,811

 

 

 

(42,712

)

 

 

(230

)

 

 

(42,942

)

 

 

440,943

 

 

 

(3,799

)

 

 

(980

)

 

 

436,164

 

 

 

1,970,601

 

 

 

(4,029

)

 

 

(980

)

 

 

1,965,592

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,321

 

 

 

3,009

 

 

 

(617

)

 

 

5,713

 

 

 

3,321

 

 

 

3,009

 

 

 

(617

)

 

 

5,713

 

Stock-based compensation expense

 

 

9,214

 

 

 

665

 

 

 

9,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,214

 

 

 

 

 

 

665

 

 

 

9,879

 

Translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(1,531

)

 

 

28

 

 

 

(1,503

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,531

)

 

 

28

 

 

 

 

 

 

(1,503

)

Balance at June 30, 2024

 

 

1,585,782

 

 

 

665

 

 

 

1,586,447

 

 

 

(44,243

)

 

 

(202

)

 

 

(44,445

)

 

 

444,264

 

 

 

(790

)

 

 

(1,597

)

 

 

441,877

 

 

 

1,986,362

 

 

 

(992

)

 

 

(932

)

 

 

1,984,438

 

 

 

 

Additional Paid-In Capital

 

 

Accumulated Other Comprehensive Loss

 

 

Accumulated Earnings

 

 

Total Stockholders' Equity

 

 

 

As Previously Reported

 

 

Other Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Balance at December 31, 2023

 

 

1,569,227

 

 

 

 

 

 

1,569,227

 

 

 

(37,431

)

 

 

(377

)

 

 

(37,808

)

 

 

438,849

 

 

 

(5,197

)

 

 

(784

)

 

 

432,868

 

 

 

1,971,203

 

 

 

(5,574

)

 

 

(784

)

 

 

1,964,845

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,415

 

 

 

4,407

 

 

 

(813

)

 

 

9,009

 

 

 

5,415

 

 

 

4,407

 

 

 

(813

)

 

 

9,009

 

Stock-based compensation expense

 

 

17,990

 

 

 

665

 

 

 

18,655

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,990

 

 

 

 

 

 

665

 

 

 

18,655

 

Translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(6,812

)

 

 

175

 

 

 

(6,637

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,812

)

 

 

175

 

 

 

 

 

 

(6,637

)

Balance at June 30, 2024

 

 

1,585,782

 

 

 

665

 

 

 

1,586,447

 

 

 

(44,243

)

 

 

(202

)

 

 

(44,445

)

 

 

444,264

 

 

 

(790

)

 

 

(1,597

)

 

 

441,877

 

 

 

1,986,362

 

 

 

(992

)

 

 

(932

)

 

 

1,984,438

 

 

 

 

 

 

Six Months Ended June 30, 2024

 

 

 

As Previously Reported

 

 

Revenue Adjustments

 

 

Other Adjustments

 

 

As Restated

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

5,415

 

 

$

4,407

 

 

$

(813

)

 

$

9,009

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

33,648

 

 

 

 

 

 

236

 

 

 

33,884

 

Amortization of debt discount and issuance costs

 

 

7,727

 

 

 

 

 

 

 

 

 

7,727

 

Stock-based compensation

 

 

17,990

 

 

 

 

 

 

665

 

 

 

18,655

 

Deferred income taxes, net

 

 

(2,634

)

 

 

(1,000

)

 

 

(119

)

 

 

(3,753

)

Operating lease right of use asset amortization

 

 

(16,349

)

 

 

 

 

 

25,065

 

 

 

8,716

 

Other

 

 

(172

)

 

 

 

 

 

275

 

 

 

103

 

Changes in operating assets and liabilities, excluding impact of acquisitions:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(1,245

)

 

 

 

 

 

 

 

 

(1,245

)

Inventories

 

 

10,474

 

 

 

 

 

 

 

 

 

10,474

 

Prepaid expenses and other assets

 

 

(1,999

)

 

 

2,700

 

 

 

(244

)

 

 

457

 

Other assets

 

 

364

 

 

 

 

 

 

 

 

 

364

 

Accounts payable

 

 

1,547

 

 

 

 

 

 

 

 

 

1,547

 

Accrued expenses

 

 

8,366

 

 

 

(6,107

)

 

 

 

 

 

2,259

 

Operating lease liabilities

 

 

23,867

 

 

 

 

 

 

(25,065

)

 

 

(1,198

)

Long-term liabilities

 

 

(101

)

 

 

 

 

 

 

 

 

(101

)

Total cash provided by operating activities

 

 

86,898

 

 

 

 

 

 

 

 

 

86,898

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Additions to capitalized software costs

 

 

(2,619

)

 

 

 

 

 

 

 

 

(2,619

)

Purchases of property, plant and equipment

 

 

(13,154

)

 

 

 

 

 

 

 

 

(13,154

)

Other investing activities

 

 

11

 

 

 

 

 

 

 

 

 

11

 

Total cash (used in) provided by investing activities

 

 

(15,762

)

 

 

 

 

 

 

 

 

(15,762

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from exercise of stock options

 

 

1,788

 

 

 

 

 

 

 

 

 

1,788

 

Payment of tax withholding obligation on vesting of restricted stock

 

 

(8,857

)

 

 

 

 

 

 

 

 

(8,857

)

Payment of earnout consideration

 

 

(7,375

)

 

 

 

 

 

 

 

 

(7,375

)

Other financing activities

 

 

(303

)

 

 

 

 

 

 

 

 

(303

)

Total cash used in financing activities

 

 

(14,747

)

 

 

 

 

 

 

 

 

(14,747

)

Effect of exchange rate changes on cash and cash equivalents

 

 

1,434

 

 

 

 

 

 

 

 

 

1,434

 

Net increase in cash and cash equivalents

 

 

57,823

 

 

 

 

 

 

 

 

 

57,823

 

Cash, cash equivalents, beginning of period

 

 

751,323

 

 

 

 

 

 

 

 

 

751,323

 

Cash and cash equivalents, end of period

 

$

809,146

 

 

$

 

 

$

 

 

$

809,146

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Assets acquired under operating leases

 

$

23,860

 

 

$

 

 

$

 

 

$

23,860

 

Fair value of shares of common stock issued for contingent consideration earnouts

 

$

5,742

 

 

$

 

 

$

 

 

$

5,742